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Human beings have showed evolution for long years associated with the changes in metabolic programs [1]. In favorable 
environmental situation, growth and reproduction programs had been continued, which were anabolic metabolism. Under 
unfavorable environmental conditions, maintenance programs were engaged, which include dormancy and defense. 
Dormancy is induced by nutrient shortage relying on energy preserving catabolic metabolism. Defense is induced by 
infections and other aggressive factors associated with supporting anabolic metabolism [1]. 
From nutritional point of view, there is the comparative perspective for human evolution between i) fasting and ii) overeating. 
The former had been observed in human being for approximately 4 million to 7 million years [2]. Food deprivation has 
brought elevated ketone bodies and intensified cognition, leading to synaptic plasticity, neurogenesis and neuroprotection. 
This mechanism shows optimal cognitive function and resistance to injury and disease.  
On the other hand, the latter has been recently observed such as non-communicable diseases (NCDs) worldwide. Food 
abundance has brought elevated insulin resistance and cognitive complacency, leading to synaptic dysfunction, impaired 
neurogenesis and neuronal degeneration. This mechanism shows suboptimal cognition and vulnerability to injury and disease 
[2].  
Primitive men had changed into present human race. They had struggled with hunger for million years. What did they usually 
live on? They sometimes got hunting animals and ate muscle, visceral organ and bone marrow. These foods consist of protein 
and fat without carbohydrate. Their blood glucose was always subnormal, and health problem was rather hypoglycemia. That 
is why human body has only insulin that decreases blood glucose.  
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A large change was observed about ten thousand years ago. It was agriculture that changed our lifestyle. They could start 
making crops such as rice, wheat, corn which content is carbohydrate. As the result, the population increased explosively in 
the continents, and several civilizations were born where people can work hard. There was industrial revolution during 18 th 
century that changed our lifestyle. People tend to have less manual labors and postprandial hyperglycemia because of refined 
white crops. At present, we have now in other industrial revolution from immobilization and computerized society. 
In contemporary society, people have continued taking too much refined cereals and carbohydrates, then insulin has been 
compelled to secrete for long. Consequently, non-communicable diseases (NCDs) such as obesity, diabetes, hyperlipidemia, 
arteriosclerosis were increasing and become medical and social problem worldwide [3].  
The management of diabetes has been crucial problem. According to International Diabetes Federation (IDF), diabetic 
prevalence has been explosively increasing [4]. It will become from 8.8% in 2015 to 10.4% in 2040. Consequently, preventing 
strategy of NCD and metabolic syndrome would be necessary. The important point would be the restriction of taking 
carbohydrate. In European and North American countries, low carbohydrate diet (LCD) was introduced by Atkins and 
Bernstein [5,6]. After that, LCD has been gradually accepted for many people and patients [7].  
In Japan, authors and colleagues have initiated LCD and continued clinical research of LCD, ketone bodies, Morbus (M) 
value, comparison of LCD and calorie restriction (CD) and so on [8,9]. For practical application, three type of diet have been 
proposed, such as super, standard and petite [10]. We are also developing educational workshop about LCD and anti-aging 
medicine through Japan LCD promotion association (JLCDPA) [11]. Furthermore, we have clarified extremely elevated 
ketone bodies in the axis of fetus, placenta, newborn and mother blood, indicating that ketone bodies would have crucial 
important role of generating energy [12]. 
Formerly, it was believed that brain can use energy from only glucose. After that, however, it is now known that ketone 
bodies (KB) can generate energy at brain and muscles, and that KB has important roles for regulating human metabolism.  
There was the research of fasting therapy with metabolic changes of hormones and free fatty acid (FFA) about 100 years ago. 
It showed several beneficial effects for various diseases, which was probably due to elevated blood KB [13]. In case of 
starvation, beta-hydroxybutyrate (βHB, 3-hydroxybutyric acid, 3-OHBA) would replace glucose as a source of energy with 
various metabolic changes [14]. It means that a switch concerning cell fuel was changed from glucose to fatty acids [14,15]. 
KB inhibit amino acid metabolism and protein turnover in skeletal muscles. This would be one of the survival mechanism 
during adaptation to the states of catabolic condition including fasting [14,15].  
From related biochemical data of the comparison among animal species, the fetus in most animals seem to be brought up by 
the energy produced from KB [16,17]. KB consist of 3 factors chemically and medically, which are βHB, acetoacetic acid 
(AcAc) and acetone [16,17]. The former two have activity as KB, and the latter has no activity. Among them, βHB is thought 
to be the fundamental main engine producing energy on land-living animals. βHB has been recognized for an energy carrier 
from liver to peripheral tissues. Furthermore, it is also an important signal via extracellular receptors and acts as an 
endogenous inhibitor of histone deacetylases (HDACs) [16,17]. 
KB has been known to have several beneficial efficacies for the nervous function and for neurological diseases. According 
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to the investigation of acetoacetyl-CoA synthetase (AACS), KB seemed to be utilized through the synthesis pathway of lipid 
substance, and to influence metabolic disorders for the nervous system [18]. 
Regarding pediatric medical problem, there are lots of children with epilepsy who are resistant to standard anti-epileptic 
medicine so far. In such cases, ketogenic diet would be worthwhile to try as a treatment. Ketogenic diet has been effective, 
whether it is either high-fat low carbohydrate ketogenic diet or meal with high ketone bodies including AcAc, βHB and 
acetone. The detail mechanisms of these meals are not clarified yet, but KB has actually anticonvulsant antiepileptic effects 
to satisfactory degree [19].   
For children, the influence of meal with little carbohydrate on the metabolic parameters has not been clarified in detail yet 
[20]. The treatment has been estimated to be effective and related practice and research has been continued at more than 250 
medical centers worldwide [21]. Clinical research on epilepsy would be expected to be developed in the future by the 
accumulation of the epileptic cases.  
Regarding medical problem for the elderly, KB would be beneficial for Alzheimer’s disease (AD). Glucose metabolism in 
the brain has been observed to be specifically reduced in AD [22]. The β-amyloid peptide Aβ will interfere with the 
cholinergic innervation [23]. KB is similarly used against epilepsy at rather high KB concentration, in which KB would 
interfere with glucose and de novo synthesis of neurotransmitter glutamate. On the other hand, KB can be used for AD at 
lower concentration. The mechanism seems to be the support of energy metabolism, with inhibiting release of gliotransmitter 
glutamate [23].  
From medical and biological points of view, current topics were described concerning the correlation among human 
metabolism and evolution, fat and ketone bodies, carbohydrate and LCD. This article would be expected to be some reference 
to various research.  
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